HLICancer•prnewswire•
Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members
Sentiment:Positive (80)
Summary
SOUTH SAN FRANCISCO, Calif., June 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive health, today announced an expansion of its $1 million pledge initiative—this time targeting late-stage pancreatic cancer. Building on the success of...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 17, 2025 by prnewswire